SE314774B - - Google Patents
Info
- Publication number
- SE314774B SE314774B SE8487/63A SE848763A SE314774B SE 314774 B SE314774 B SE 314774B SE 8487/63 A SE8487/63 A SE 8487/63A SE 848763 A SE848763 A SE 848763A SE 314774 B SE314774 B SE 314774B
- Authority
- SE
- Sweden
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/165—Mumps or measles virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/275—Poxviridae, e.g. avipoxvirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/275—Poxviridae, e.g. avipoxvirus
- A61K39/285—Vaccinia virus or variola virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US217293A US3186908A (en) | 1962-08-16 | 1962-08-16 | Calcium lactobionate stabilization of labile antigenic virus vaccine materials |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE314774B true SE314774B (show.php) | 1969-09-15 |
Family
ID=22810442
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8487/63A SE314774B (show.php) | 1962-08-16 | 1963-08-01 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US3186908A (show.php) |
| BR (1) | BR6351350D0 (show.php) |
| CH (1) | CH412201A (show.php) |
| DE (1) | DE1227615B (show.php) |
| DK (1) | DK104193C (show.php) |
| ES (1) | ES290512A1 (show.php) |
| FI (1) | FI40108C (show.php) |
| FR (1) | FR1594506A (show.php) |
| GB (1) | GB1049386A (show.php) |
| SE (1) | SE314774B (show.php) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4380582A (en) * | 1965-07-09 | 1983-04-19 | The United States Of America As Represented By The Secretary Of The Army | Preparation of dry variola virus |
| DE1617457A1 (de) * | 1966-12-16 | 1972-04-20 | Erba Carlo Spa | Verfahren zur Stabilisierung von Zubereitungen interferierender Virusprodukte |
| FR2076787A5 (en) * | 1970-01-28 | 1971-10-15 | Merieux Inst | Lyophilisation stabiliser - for viruses contg potassium phosphate lactose and albumin |
| JPS5716823A (en) * | 1980-07-03 | 1982-01-28 | Green Cross Corp:The | Live mumps vaccine pharmaceutical and stabilizing method |
| FR2505657A1 (fr) * | 1981-05-13 | 1982-11-19 | Pasteur Institut | Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation |
| JPS59163313A (ja) * | 1983-03-09 | 1984-09-14 | Teijin Ltd | 経鼻投与用ペプチドホルモン類組成物 |
| GB0218821D0 (en) * | 2002-08-13 | 2002-09-18 | Glaxosmithkline Biolog Sa | Novel compositions |
| CN116115766B (zh) * | 2023-02-06 | 2024-04-09 | 广东永顺生物制药股份有限公司 | 一种活疫苗耐热冻干保护剂及其制备方法与应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA603832A (en) * | 1960-08-23 | J. Scott William | Method and means for the dried storage of micro-organisms | |
| US2186975A (en) * | 1933-04-10 | 1940-01-16 | Horace S Isbell | Crystalline calcium lactobionate calcium bromide and process for making the same |
| GB716920A (en) * | 1951-07-31 | 1954-10-20 | Andre Jean Pierre Joseph Thoma | A process for the mass production and treatment of pathogenic viruses and substances which accompany them |
| US2879202A (en) * | 1954-11-05 | 1959-03-24 | American Cyanamid Co | Stabilization of live viral vaccines by hexahydric alcohols |
| US2912361A (en) * | 1956-11-28 | 1959-11-10 | Sterling Drug Inc | Canine distemper vaccine and its preparation |
| US2946724A (en) * | 1957-05-29 | 1960-07-26 | American Cyanamid Co | Stable poliomyelitis live virus vaccine |
| GB899011A (en) * | 1958-03-14 | 1962-06-20 | Upjohn Co | Rubeola vaccine and process |
| US3031378A (en) * | 1959-05-30 | 1962-04-24 | Ishidate Morizo | Method of inactivating viruses |
| GB900115A (en) * | 1960-06-15 | 1962-07-04 | Armour & Co | Improvements in or relating to trypsin solutions |
-
1962
- 1962-08-16 US US217293A patent/US3186908A/en not_active Expired - Lifetime
-
1963
- 1963-08-01 BR BR151350/63A patent/BR6351350D0/pt unknown
- 1963-08-01 FR FR1594506D patent/FR1594506A/fr not_active Expired
- 1963-08-01 FI FI150063A patent/FI40108C/fi active
- 1963-08-01 DK DK368963AA patent/DK104193C/da active
- 1963-08-01 ES ES290512A patent/ES290512A1/es not_active Expired
- 1963-08-01 SE SE8487/63A patent/SE314774B/xx unknown
- 1963-08-01 DE DEP32328A patent/DE1227615B/de active Pending
- 1963-08-01 CH CH954763A patent/CH412201A/fr unknown
- 1963-08-01 GB GB30644/63A patent/GB1049386A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DK104193C (da) | 1966-04-18 |
| FR1594506A (show.php) | 1970-06-08 |
| CH412201A (fr) | 1966-04-30 |
| DE1227615B (de) | 1966-10-27 |
| ES290512A1 (es) | 1963-11-16 |
| GB1049386A (en) | 1966-11-23 |
| FI40108B (show.php) | 1968-06-28 |
| BR6351350D0 (pt) | 1973-08-02 |
| US3186908A (en) | 1965-06-01 |
| FI40108C (fi) | 1968-10-10 |